Download in electronic PDF format for $25



Search the Complete Journal Archives

Pediatric Health Care: An Introduction

Author(s):  Williams LaVonn A

Issue:  Jan/Feb 2013 - Volume 17, Number 1
View All Articles in Issue

Abstract:  Pediatric healthcare, to include compounded medications, is achallenge for healthcare providers. Although current studies have provided important new informationabout drug safety and effectiveness for children, carrying outstudies in children is difficult. Age-appropriate equipment and medical techniques, along with specialists who are sensitive to a child’s concerns, are a must. Therefore, experts must build a foundationand resources that are needed to conduct studies involving pediatric patients. Compounding pharmacists welcome reliable data from which to use when compounding medications for such an elite group of patients.

Related Keywords: LaVonn A. Williams, children, child, infants, drug safety, dosages, off-label medication use, loratidine, fentanyl, fluvoxamine maleate, midazolam hydrochloride, gabapentin, famotidine, sevoflurane, United States Food and Drug Administration, FDA

Related Categories: LEGAL, PEDIATRICS

Printer-Friendly Version

Related Articles from IJPC
Title (Click for Abstract / Details) Author Issue Page View/Buy
Pediatric Health Care: An Introduction Williams LaVonn A Jan/Feb 2013 6-8 Buy
Veterinary Transdermal Medications: A to Z Davidson Gigi S Mar/Apr 2003 106 Buy
PreScription: 2017 Pharmacy Compounding Issues: The U.S. Food and Drug Administration, Harzardous Drugs, and Wasted Drugs Allen Loyd V Jr Sep/Oct 2017 356 Buy
Discrepancies in the Law and the U.S. Food and Drug Administration Pharmacy Compounding Compliance Policy Guidelines Allen Loyd V Jr Jul/Aug 2016 351 View Sample
Pediatric Compounding: Coloring Outside the Lines Preckshot John Jan/Feb 2001 6 Buy
U.S. Food and Drug Administration Proposed Guidance Document: Compounding Animal Drugs from Bulk Substances Miller David G Jul/Aug 2015 303-305 Buy
Drug Shortages & Discontinued Drugs: The Effects on Patients and Healthcare Providers Allen Loyd V Jr, Williams LaVonn A Jul/Aug 2012 294-298 Buy
The Role of Drug Promotion in the Prescription of Hormone Replacement Therapy in the United States Stephenson Kenna, Jones William, Stephenson Douglas M M May/Jun 2006 175-183 Buy
U.S. Food and Drug Administration "Evaluation Criteria" for Difficult to Compound Drugs Allen Loyd V Jr Nov/Dec 2015 487-488 Buy
U.S. Food and Drug Administration List of Drugs NOT to be Used in Compounded Medications for Humans (The Negative List) Nov/Dec 2016 457-458 Buy